Bold letters indicate the PAM (NGG; Protospacer. Adjacent Motif) site. Figure S3 T7 endonuclease assay for detecting DNA repair event in the dsRED sensor.
Tromsø. (m, n=1,387) rs7958311 g. A G 44.5±3.9 44.7±3.8 44.5±4.1 85.3±12.0 87.3±13.5 88.0±13.9 26.6±3.9 27.2±3.8 27.3±3.9 30.5 27.7 28.8 rs208296.
ratios. Shown for (a) Syt-1 samples in 1 mM EGTA and (b) in 100 μM Ca2+. The numbers indicate the ratio of acceptor liposomes relative to the donor liposomes.
Prothioconazole-desthio, CYP51B side chain (Tyr136) and heme cofactor are shown in ball-and-stick representation. Ligand-metal bonds coloured in purple ...
Figure S2. Comparison of Medicago sativa linkage group 3 maps with the M. truncatula chromosome 3 physical map. The parental alfalfa genetic maps are ...
1.1 x 101. 6.0 x 10-1 ± 2.0 x 10-2. 5.8 x 10-1 ± 2.0 x 10-2. 1.5 x 10-1 ± 4.3 x 10-3. Sample 4. 2.3 x 101. 7.3 x 10-1 ± 4.6 x 10-2. 7.2 x 10-1 ± 1.4 x 10-2. 3.2 x 10-1 ...
Acta Neuropathol (2011) 121:397â405. Grade II - Pleomorphic xanthoastrocytoma ... Acta Neuropathol (2011) 121:397â405. Grade III - Anaplastic Astrocytoma.
List of figures: Figure 1: Targeted PknG peptide (INSFGYLYG) identified exclusively in the wild type M. bovis. BCG and not in the knock-out mutant. Figure 2.
JURKAT cell line is a negative control. ... CT, cancer tissue; CC, cancer cell line; and NC, ... aggressive NK-cell leukemia; ENKL, extranodal NK-cell lymphoma).
#Corresponding Author: Michael J. Sadowsky, BioTechnology Institute, University of. Minnesota, 140 Gortner Lab, 1479 Gortner Ave, Saint Paul, MN 55108; ...
Jean-Philippe Brosseau. 1#. , Chung-Ping Liao. 1# .... Shields, C. L., Kaliki, S., Furuta, M., Mashayekhi, A. & Shields, J. A. Clinical spectrum and prognosis of ...
lysine, collagen TypeI, gelatin, fibronectin, and laminin. The cells were treated with various concentrations of manumycin A (MA) or control vehicle (DMSO) for 48 ...
T12 partially stabilized FAs, mVin and T12-A974K had the opposite effect of increasing FA instability. Solid curves are best fits to an exponential decay profile ...
Don’t sort alphabetically Argentina Australia Austria Belgium Brazil Canada China France Germany India Indonesia Italy Japan Korea, Rep. Mexico Netherlands Norway Poland Russian Federation Spain Sweden Switzerland Turkey United Kingdom United States
● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●
0
5
10
15
Health care spending (% GDP)
United States Netherlands France Canada Germany Switzerland Austria Belgium Italy Spain Sweden United Kingdom Japan Norway Australia Brazil Argentina Korea, Rep. Poland Turkey Russian Federation Mexico China India Indonesia